COMBIHALE FB-200 INHALER

Description

COMBIHALE FB-200 Inhaler combines Formoterol Fumarate (200 mcg), a long-acting beta-2 agonist, and Budesonide (200 mcg), an inhaled corticosteroid, in a metered-dose inhaler designed for effective treatment of asthma and chronic obstructive pulmonary disease (COPD).

Formoterol relaxes bronchial muscles to open airways, providing sustained bronchodilation, while budesonide reduces airway inflammation to prevent exacerbations and improve lung function. This inhaler is intended for regular maintenance therapy, helping patients control respiratory symptoms and reduce flare-ups.

Key Benefits:

• Provides dual bronchodilator and anti-inflammatory action

• Helps prevent asthma attacks and COPD exacerbations

• Metered-dose inhaler for precise and easy administration

• Improves breathing and lung capacity

Indications:

• Asthma maintenance therapy

• Management of chronic obstructive pulmonary disease (COPD)

Dosage:
As prescribed, typically 1-2 puffs twice daily.

Precautions:
Not for relief of acute bronchospasm. Use under medical supervision. Possible side effects include oral thrush and tremors; rinse mouth after use.